180 Life Sciences (ATNF) Competitors $1.05 -0.10 (-8.70%) Closing price 05/21/2025 03:59 PM EasternExtended Trading$1.02 -0.03 (-2.86%) As of 05/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATNF vs. ABVC, KALA, LGVN, ANVS, SLGL, LIAN, VOR, CVM, ELEV, and BIVIShould you be buying 180 Life Sciences stock or one of its competitors? The main competitors of 180 Life Sciences include ABVC BioPharma (ABVC), KALA BIO (KALA), Longeveron (LGVN), Annovis Bio (ANVS), Sol-Gel Technologies (SLGL), LianBio (LIAN), Vor Biopharma (VOR), CEL-SCI (CVM), Elevation Oncology (ELEV), and BioVie (BIVI). These companies are all part of the "pharmaceutical products" industry. 180 Life Sciences vs. ABVC BioPharma KALA BIO Longeveron Annovis Bio Sol-Gel Technologies LianBio Vor Biopharma CEL-SCI Elevation Oncology BioVie 180 Life Sciences (NASDAQ:ATNF) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership. Does the MarketBeat Community prefer ATNF or ABVC? 180 Life Sciences received 2 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesOutperform Votes216.67%Underperform Votes1083.33% ABVC BioPharmaN/AN/A Do institutionals and insiders believe in ATNF or ABVC? 4.1% of 180 Life Sciences shares are owned by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are owned by institutional investors. 0.2% of 180 Life Sciences shares are owned by insiders. Comparatively, 11.9% of ABVC BioPharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation & earnings, ATNF or ABVC? ABVC BioPharma has higher revenue and earnings than 180 Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/A-$19.93MN/AN/AABVC BioPharma$508.38K39.26-$10.52M-$0.13-9.15 Is ATNF or ABVC more profitable? 180 Life Sciences has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat 180 Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A -558.93% -54.10% ABVC BioPharma -1,619.65%-104.94%-56.81% Which has more volatility & risk, ATNF or ABVC? 180 Life Sciences has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, ABVC BioPharma has a beta of 0.06, suggesting that its share price is 94% less volatile than the S&P 500. Does the media refer more to ATNF or ABVC? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.38 beat ABVC BioPharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive ABVC BioPharma Neutral Summary180 Life Sciences and ABVC BioPharma tied by winning 5 of the 10 factors compared between the two stocks. Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATNF vs. The Competition Export to ExcelMetric180 Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.98M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E RatioN/A8.9226.8419.71Price / SalesN/A253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book-4.386.466.794.50Net Income-$19.93M$143.98M$3.23B$248.18M7 Day Performance-10.26%2.03%1.53%0.20%1 Month Performance19.32%4.11%10.05%12.37%1 Year Performance-39.66%-2.87%16.71%7.04% 180 Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATNF180 Life SciencesN/A$1.05-8.7%N/A-47.2%$5.98MN/A0.007Positive NewsEarnings ReportABVCABVC BioPharma0.1955 of 5 stars$1.36+12.4%N/A+10.2%$22.81M$508,384.00-1.5830Gap DownKALAKALA BIO3.5208 of 5 stars$3.50+2.3%$15.00+328.6%-42.7%$22.07M$3.89M-0.2830Positive NewsGap UpLGVNLongeveron2.8023 of 5 stars$1.47+9.7%$8.67+489.6%+11.8%$21.94M$2.39M-0.2320News CoverageAnalyst RevisionGap UpANVSAnnovis Bio1.6864 of 5 stars$1.54+0.6%$40.67+2,542.4%-75.4%$21.91MN/A-0.353Gap UpSLGLSol-Gel Technologies2.1769 of 5 stars$7.57-3.6%$50.00+560.4%-2.5%$21.87M$11.54M-22.2750Gap UpLIANLianBioN/A$0.20flatN/A+21.3%$21.61MN/A-0.25110Gap DownVORVor Biopharma2.7944 of 5 stars$0.17+14.0%$7.06+3,991.1%-89.4%$21.54MN/A-0.10140High Trading VolumeCVMCEL-SCIN/A$0.25+2.9%N/A-88.5%$21.37MN/A-0.5343News CoverageELEVElevation Oncology2.9143 of 5 stars$0.36+5.0%$3.39+839.7%-91.5%$21.34MN/A-0.4440Earnings ReportBIVIBioVie2.7115 of 5 stars$1.15+2.7%$3.00+160.9%+106.7%$21.22MN/A-0.1210 Related Companies and Tools Related Companies ABVC Competitors KALA Competitors LGVN Competitors ANVS Competitors SLGL Competitors LIAN Competitors VOR Competitors CVM Competitors ELEV Competitors BIVI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATNF) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATNF Stock Free ATNF Stock Alerts